NJ Commission on Brain Injury Research Individual Research Grant

The New Jersey Commission on Brain Injury Research administers a statewide research funding program designed to advance scientific understanding and treatment of traumatic brain injury. Established through state legislation in 2004, the Commission is tasked with supporting innovative research projects, fostering collaboration among researchers, and promoting the development of interventions and cures for brain injury-related disabilities. The program is funded through the New Jersey Brain Injury Research Fund and reflects a broader public health priority to address the significant medical, economic, and social burden associated with brain injuries across the state. The primary purpose of this funding opportunity is to support research that contributes to neural repair, regeneration, and improved clinical outcomes for individuals affected by traumatic brain injury. The program emphasizes both basic and clinical research, including studies on neuronal growth, rehabilitation strategies, epidemiological analyses, and innovative therapeutic interventions. Funding is intended to catalyze new research directions and generate preliminary data that can lead to larger-scale funding from federal or external sources, rather than to provide long-term financial support. Funding is available across multiple grant types, including Individual Research Grants, Pilot Research Grants, and Fellowship awards. Individual Research Grants provide up to one hundred fifty thousand dollars per year in direct costs for up to three years, with additional indirect costs allowed. Pilot grants offer smaller-scale funding to support exploratory or early-stage projects, while fellowship awards support graduate students and postdoctoral researchers. Funds may be used for personnel, equipment, research activities, and limited travel, but may not be used for construction, tuition, or international travel. Matching funds are not required, though applicants must demonstrate institutional support and sound financial management. Eligibility is restricted to applicants affiliated with qualified research institutions located within the State of New Jersey. Eligible applicants include independent investigators, senior scientists, postdoctoral fellows, and graduate students, provided they are employed by or affiliated with a New Jersey-based academic institution, research organization, or similar entity. While individuals of any nationality may apply, unaffiliated individuals are not eligible. Collaborative projects involving out-of-state or international partners are permitted, provided the primary affiliation remains within New Jersey. Applications must be submitted electronically through the System for Administering Grants Electronically. The submission process requires completion of organizational and project-specific forms, along with supporting documentation such as institutional certifications, compliance materials, and a scientific narrative. The narrative is limited to ten pages and must include both a technical abstract and a lay summary. Additional required components may include letters of support, budget documentation, and compliance approvals related to human subjects, animal welfare, or recombinant DNA, depending on the nature of the research. The application timeline for the current cycle begins with the release of program guidelines and application availability on July first, two thousand twenty six. Applications must be submitted by October fifth, two thousand twenty six at five pm Eastern Time. Fellowship reference letters are due in mid November, and applicants will be notified of funding decisions by March thirty first, two thousand twenty seven. Awards are expected to begin on or around April first, two thousand twenty seven, with multi year funding contingent upon annual progress reports and continued availability of funds. Applications undergo a multi stage review process, including administrative screening, relevance review, and scientific merit evaluation. Review criteria include significance, innovation, experimental design, investigator qualifications, and alignment with program priorities. Final funding decisions are made by the Commission. The program is recurring annually, and future cycles are expected to follow a similar timeline, supporting the Commission’s ongoing mission to advance brain injury research and improve outcomes for affected individuals.

Align proposal with NJCBIR priorities on brain injury research emphasize innovation and interdisciplinary collaboration ensure strong experimental design and clear clinical relevance demonstrate institutional support and compliance readiness